Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Specimen Collection | 4 | 2017 | 238 | 1.430 |
Why?
|
Phlebotomy | 7 | 2017 | 138 | 1.270 |
Why?
|
Troponin I | 12 | 2015 | 662 | 0.960 |
Why?
|
Creatine Kinase, MB Form | 2 | 2015 | 202 | 0.940 |
Why?
|
Diagnostic Tests, Routine | 4 | 2015 | 790 | 0.850 |
Why?
|
Clinical Laboratory Information Systems | 5 | 2017 | 108 | 0.840 |
Why?
|
Workflow | 7 | 2021 | 859 | 0.770 |
Why?
|
Automation, Laboratory | 1 | 2021 | 102 | 0.730 |
Why?
|
Vancomycin | 2 | 2013 | 506 | 0.660 |
Why?
|
Drug Monitoring | 5 | 2013 | 965 | 0.660 |
Why?
|
Myoglobin | 5 | 2005 | 158 | 0.600 |
Why?
|
Pulmonary Surfactants | 4 | 2004 | 169 | 0.530 |
Why?
|
Laboratories | 5 | 2021 | 463 | 0.490 |
Why?
|
Creatine Kinase | 7 | 2014 | 684 | 0.460 |
Why?
|
Chemistry, Clinical | 3 | 2007 | 64 | 0.430 |
Why?
|
Laboratories, Hospital | 7 | 2017 | 192 | 0.400 |
Why?
|
Acute Coronary Syndrome | 2 | 2015 | 2194 | 0.400 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3492 | 0.390 |
Why?
|
Fetal Organ Maturity | 8 | 2004 | 83 | 0.380 |
Why?
|
Efficiency, Organizational | 3 | 2017 | 699 | 0.360 |
Why?
|
Blood Glucose | 4 | 2022 | 6435 | 0.360 |
Why?
|
Myocardial Infarction | 13 | 2015 | 11521 | 0.350 |
Why?
|
Albumins | 6 | 2005 | 577 | 0.350 |
Why?
|
Thrombolytic Therapy | 5 | 2005 | 2055 | 0.340 |
Why?
|
Glucose | 1 | 2022 | 4352 | 0.340 |
Why?
|
Amniotic Fluid | 5 | 2004 | 381 | 0.340 |
Why?
|
Respiratory Distress Syndrome, Newborn | 7 | 2006 | 239 | 0.330 |
Why?
|
Vascular Patency | 2 | 2005 | 917 | 0.320 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 395 | 0.290 |
Why?
|
Electronic Health Records | 4 | 2017 | 4879 | 0.280 |
Why?
|
Phosphatidylcholines | 3 | 2000 | 406 | 0.270 |
Why?
|
Pregnancy in Diabetics | 2 | 2000 | 198 | 0.270 |
Why?
|
Clinical Laboratory Techniques | 5 | 2012 | 749 | 0.250 |
Why?
|
Reference Standards | 2 | 2022 | 1014 | 0.240 |
Why?
|
Lung | 8 | 2004 | 10099 | 0.240 |
Why?
|
Urinalysis | 2 | 2018 | 370 | 0.220 |
Why?
|
Angina, Unstable | 4 | 2000 | 893 | 0.210 |
Why?
|
Clinical Enzyme Tests | 2 | 1999 | 114 | 0.210 |
Why?
|
Pathology, Clinical | 3 | 2002 | 377 | 0.200 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 475 | 0.190 |
Why?
|
Education, Medical | 1 | 2013 | 1742 | 0.190 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2002 | 219 | 0.170 |
Why?
|
Blood Coagulation Tests | 1 | 2021 | 270 | 0.170 |
Why?
|
Quality of Health Care | 2 | 2014 | 4339 | 0.170 |
Why?
|
Troponin | 3 | 2015 | 535 | 0.170 |
Why?
|
Gestational Age | 7 | 2004 | 3621 | 0.170 |
Why?
|
Unnecessary Procedures | 3 | 2003 | 419 | 0.160 |
Why?
|
Diagnostic Errors | 3 | 2016 | 1281 | 0.160 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2014 | 497 | 0.160 |
Why?
|
Hyperparathyroidism | 1 | 1999 | 339 | 0.150 |
Why?
|
Myocardium | 2 | 2007 | 4790 | 0.150 |
Why?
|
Data Display | 1 | 1997 | 174 | 0.140 |
Why?
|
Outpatients | 4 | 2017 | 1603 | 0.140 |
Why?
|
Chromatography, Liquid | 2 | 2018 | 997 | 0.140 |
Why?
|
Blood Cell Count | 2 | 2017 | 406 | 0.140 |
Why?
|
Immunoassay | 3 | 2018 | 746 | 0.140 |
Why?
|
Platelet Aggregation | 2 | 1991 | 769 | 0.140 |
Why?
|
Humans | 74 | 2023 | 768970 | 0.140 |
Why?
|
Computers | 1 | 1999 | 592 | 0.130 |
Why?
|
Substance Abuse Detection | 1 | 2018 | 301 | 0.130 |
Why?
|
Hospital Charges | 1 | 1997 | 351 | 0.130 |
Why?
|
Pathology Department, Hospital | 1 | 2015 | 10 | 0.130 |
Why?
|
Hospital Information Systems | 2 | 2017 | 394 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2021 | 1161 | 0.120 |
Why?
|
Utilization Review | 2 | 2015 | 384 | 0.120 |
Why?
|
Isoenzymes | 5 | 1999 | 1687 | 0.120 |
Why?
|
Heart Diseases | 1 | 2007 | 2819 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 2 | 2018 | 1197 | 0.120 |
Why?
|
Point-of-Care Systems | 2 | 2022 | 1240 | 0.110 |
Why?
|
Tissue Plasminogen Activator | 1 | 1999 | 1165 | 0.110 |
Why?
|
Cost Control | 2 | 2015 | 627 | 0.110 |
Why?
|
Coronary Vessels | 1 | 2005 | 3124 | 0.110 |
Why?
|
Academic Medical Centers | 6 | 2017 | 2784 | 0.110 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7478 | 0.110 |
Why?
|
Sensitivity and Specificity | 10 | 2023 | 14752 | 0.110 |
Why?
|
Hospitals, Teaching | 3 | 2012 | 1159 | 0.100 |
Why?
|
Time Factors | 10 | 2017 | 40261 | 0.100 |
Why?
|
Models, Biological | 2 | 2002 | 9499 | 0.100 |
Why?
|
Time | 1 | 2013 | 552 | 0.100 |
Why?
|
Reference Values | 3 | 2014 | 4940 | 0.090 |
Why?
|
Myeloma Proteins | 1 | 2010 | 71 | 0.090 |
Why?
|
Predictive Value of Tests | 9 | 2007 | 15471 | 0.090 |
Why?
|
Preoperative Care | 1 | 1999 | 2258 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2000 | 1789 | 0.090 |
Why?
|
Potassium | 1 | 2014 | 1315 | 0.090 |
Why?
|
Patient Identification Systems | 1 | 2010 | 75 | 0.080 |
Why?
|
Cost Savings | 2 | 2013 | 915 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 1669 | 0.080 |
Why?
|
ROC Curve | 5 | 2006 | 3629 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3904 | 0.080 |
Why?
|
Evidence-Based Practice | 1 | 2012 | 500 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2000 | 2493 | 0.070 |
Why?
|
Prostate-Specific Antigen | 3 | 2001 | 2487 | 0.070 |
Why?
|
Troponin T | 2 | 2015 | 787 | 0.060 |
Why?
|
Parathyroid Hormone | 2 | 2005 | 1803 | 0.060 |
Why?
|
Physical Exertion | 1 | 1988 | 668 | 0.060 |
Why?
|
Postmenopause | 1 | 1995 | 2519 | 0.060 |
Why?
|
Myocardial Ischemia | 2 | 2007 | 2139 | 0.060 |
Why?
|
Female | 29 | 2018 | 397515 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 2 | 2006 | 1178 | 0.060 |
Why?
|
Inpatients | 2 | 2014 | 2569 | 0.060 |
Why?
|
Emergency Service, Hospital | 2 | 2015 | 7957 | 0.060 |
Why?
|
Phosphoproteins | 1 | 1993 | 2452 | 0.060 |
Why?
|
Medical Errors | 2 | 2010 | 1262 | 0.060 |
Why?
|
Boston | 6 | 2014 | 9377 | 0.060 |
Why?
|
Autopsy | 1 | 2007 | 1013 | 0.060 |
Why?
|
Nurses | 1 | 2013 | 2501 | 0.060 |
Why?
|
Program Evaluation | 1 | 2012 | 2508 | 0.050 |
Why?
|
Parathyroid Neoplasms | 1 | 2005 | 244 | 0.050 |
Why?
|
Natriuretic Peptides | 1 | 2004 | 156 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2005 | 528 | 0.050 |
Why?
|
Male | 24 | 2015 | 365203 | 0.050 |
Why?
|
Middle Aged | 21 | 2014 | 223737 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2014 | 2784 | 0.050 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2003 | 102 | 0.050 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2003 | 146 | 0.050 |
Why?
|
Aspirin | 2 | 1991 | 3135 | 0.050 |
Why?
|
Calcium | 1 | 1995 | 5792 | 0.050 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2003 | 197 | 0.050 |
Why?
|
Silicone Gels | 1 | 2001 | 39 | 0.050 |
Why?
|
Medication Adherence | 1 | 2013 | 2192 | 0.050 |
Why?
|
Hospital Bed Capacity, 500 and over | 2 | 1997 | 113 | 0.050 |
Why?
|
Medical Order Entry Systems | 1 | 2006 | 523 | 0.040 |
Why?
|
Electrocardiography | 3 | 2005 | 6413 | 0.040 |
Why?
|
Myocardial Reperfusion | 1 | 2001 | 339 | 0.040 |
Why?
|
Aged | 16 | 2014 | 171786 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2005 | 1626 | 0.040 |
Why?
|
Cryopreservation | 1 | 2005 | 734 | 0.040 |
Why?
|
Reminder Systems | 1 | 2003 | 388 | 0.040 |
Why?
|
Anticonvulsants | 2 | 2003 | 1924 | 0.040 |
Why?
|
Hospital Communication Systems | 1 | 1999 | 48 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1999 | 184 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1991 | 2763 | 0.040 |
Why?
|
Oximetry | 1 | 2002 | 462 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2000 | 187 | 0.040 |
Why?
|
Infant, Newborn | 7 | 2006 | 26428 | 0.040 |
Why?
|
Pregnancy | 6 | 2004 | 30265 | 0.040 |
Why?
|
Twins | 1 | 2000 | 341 | 0.040 |
Why?
|
Up-Regulation | 1 | 2007 | 4148 | 0.040 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 2001 | 283 | 0.040 |
Why?
|
Paraproteinemias | 1 | 2001 | 252 | 0.040 |
Why?
|
Enoxaparin | 1 | 2000 | 391 | 0.040 |
Why?
|
Regression Analysis | 4 | 2001 | 6346 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1528 | 0.040 |
Why?
|
Digoxin | 1 | 1999 | 246 | 0.040 |
Why?
|
Chest Pain | 1 | 2005 | 1101 | 0.040 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2001 | 239 | 0.040 |
Why?
|
Therapy, Computer-Assisted | 1 | 1999 | 265 | 0.040 |
Why?
|
Microcirculation | 1 | 2002 | 1281 | 0.040 |
Why?
|
Breast Implants | 1 | 2001 | 414 | 0.030 |
Why?
|
Attitude to Computers | 1 | 2017 | 196 | 0.030 |
Why?
|
Ischemia | 1 | 2005 | 1900 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 963 | 0.030 |
Why?
|
Computer Systems | 1 | 1997 | 470 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 1999 | 544 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2014 | 59739 | 0.030 |
Why?
|
Tuberculosis, Urogenital | 1 | 1974 | 9 | 0.030 |
Why?
|
Adenoma | 1 | 2005 | 2163 | 0.030 |
Why?
|
Surface-Active Agents | 1 | 1994 | 152 | 0.030 |
Why?
|
Prognosis | 6 | 2000 | 30046 | 0.030 |
Why?
|
Interinstitutional Relations | 1 | 1995 | 236 | 0.030 |
Why?
|
Radiology Department, Hospital | 1 | 1997 | 409 | 0.030 |
Why?
|
Prospective Studies | 7 | 2015 | 54962 | 0.030 |
Why?
|
Hospitals, University | 1 | 1995 | 570 | 0.030 |
Why?
|
Clinical Protocols | 1 | 1999 | 1445 | 0.030 |
Why?
|
Medical Staff, Hospital | 1 | 1997 | 603 | 0.030 |
Why?
|
Morphine Derivatives | 1 | 2013 | 43 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2000 | 3447 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 1999 | 13021 | 0.030 |
Why?
|
Casein Kinase II | 1 | 1993 | 121 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2012 | 81903 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2017 | 9080 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2017 | 1081 | 0.030 |
Why?
|
Erythrocytes | 1 | 2002 | 2421 | 0.030 |
Why?
|
Risk Assessment | 5 | 2004 | 24333 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2010 | 5196 | 0.030 |
Why?
|
Respiration Disorders | 1 | 1996 | 365 | 0.030 |
Why?
|
Tramadol | 1 | 2013 | 63 | 0.030 |
Why?
|
Medical Records | 1 | 1998 | 1411 | 0.030 |
Why?
|
Phosphopeptides | 1 | 1993 | 240 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 1629 | 0.020 |
Why?
|
Models, Statistical | 1 | 2006 | 5110 | 0.020 |
Why?
|
Microscopy | 1 | 2017 | 910 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 1993 | 558 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3215 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1999 | 1798 | 0.020 |
Why?
|
Capillaries | 1 | 1994 | 756 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2000 | 2080 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4568 | 0.020 |
Why?
|
CHO Cells | 1 | 1993 | 1379 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2005 | 20245 | 0.020 |
Why?
|
Cricetinae | 1 | 1993 | 2423 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1993 | 1536 | 0.020 |
Why?
|
Fentanyl | 1 | 2013 | 450 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 1993 | 838 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 2734 | 0.020 |
Why?
|
Substrate Specificity | 1 | 1993 | 1751 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4168 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 6569 | 0.020 |
Why?
|
Cattle | 1 | 1993 | 3819 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 1999 | 39394 | 0.020 |
Why?
|
Massachusetts | 2 | 1997 | 8894 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 1997 | 12095 | 0.020 |
Why?
|
Amino Acids | 1 | 1993 | 1716 | 0.020 |
Why?
|
Patient Selection | 1 | 1999 | 4265 | 0.020 |
Why?
|
Capital Expenditures | 1 | 2006 | 27 | 0.020 |
Why?
|
Brain | 1 | 1993 | 27453 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7460 | 0.020 |
Why?
|
Ultrasonography | 1 | 1999 | 6002 | 0.020 |
Why?
|
Quality Assurance, Health Care | 2 | 2012 | 2182 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 1974 | 1397 | 0.020 |
Why?
|
Transfection | 1 | 1993 | 5763 | 0.020 |
Why?
|
Specimen Handling | 1 | 2010 | 708 | 0.020 |
Why?
|
Risk | 3 | 2006 | 9621 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2011 | 2360 | 0.020 |
Why?
|
Buprenorphine | 1 | 2013 | 667 | 0.020 |
Why?
|
Critical Care | 1 | 1998 | 2716 | 0.020 |
Why?
|
Survival Rate | 1 | 1999 | 12873 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2004 | 15951 | 0.010 |
Why?
|
Logistic Models | 3 | 2006 | 13318 | 0.010 |
Why?
|
Frozen Sections | 1 | 2005 | 154 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1994 | 2714 | 0.010 |
Why?
|
Investments | 1 | 2006 | 149 | 0.010 |
Why?
|
Budgets | 1 | 2006 | 232 | 0.010 |
Why?
|
Odds Ratio | 2 | 2012 | 9684 | 0.010 |
Why?
|
Pilot Projects | 1 | 1997 | 8748 | 0.010 |
Why?
|
Fluorescence Polarization | 1 | 2004 | 139 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1993 | 6512 | 0.010 |
Why?
|
Atrial Natriuretic Factor | 1 | 2004 | 350 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3928 | 0.010 |
Why?
|
Parathyroidectomy | 1 | 2005 | 244 | 0.010 |
Why?
|
Adult | 6 | 2000 | 223851 | 0.010 |
Why?
|
Health Planning Guidelines | 1 | 2003 | 153 | 0.010 |
Why?
|
Phosphorylation | 1 | 1993 | 8317 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2015 | 3628 | 0.010 |
Why?
|
Pharmacy Service, Hospital | 1 | 2003 | 134 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2018 | 4423 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1993 | 13427 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1997 | 8055 | 0.010 |
Why?
|
alpha 1-Antichymotrypsin | 1 | 2001 | 18 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8749 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2483 | 0.010 |
Why?
|
Autoanalysis | 1 | 2001 | 70 | 0.010 |
Why?
|
Evidence-Based Medicine | 2 | 2003 | 3709 | 0.010 |
Why?
|
Hospitalization | 2 | 1998 | 10847 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1993 | 17629 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2004 | 1998 | 0.010 |
Why?
|
Protein Precursors | 1 | 2004 | 1135 | 0.010 |
Why?
|
Prostatic Neoplasms | 2 | 2000 | 11230 | 0.010 |
Why?
|
Cost-Benefit Analysis | 2 | 2006 | 5544 | 0.010 |
Why?
|
Sphingomyelins | 1 | 2000 | 105 | 0.010 |
Why?
|
Drug Utilization | 1 | 2006 | 1191 | 0.010 |
Why?
|
Retreatment | 1 | 2001 | 600 | 0.010 |
Why?
|
Luminescent Measurements | 1 | 2001 | 342 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2005 | 950 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2001 | 1705 | 0.010 |
Why?
|
Diseases in Twins | 1 | 2000 | 447 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2001 | 65480 | 0.010 |
Why?
|
Drug Costs | 1 | 2006 | 1198 | 0.010 |
Why?
|
United States | 2 | 2012 | 73186 | 0.010 |
Why?
|
Rats | 1 | 1993 | 23786 | 0.010 |
Why?
|
Pericardium | 1 | 2001 | 679 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2003 | 1406 | 0.010 |
Why?
|
Exercise Test | 1 | 2004 | 2187 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 8094 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2005 | 6236 | 0.010 |
Why?
|
Benchmarking | 1 | 2003 | 1059 | 0.010 |
Why?
|
Enzyme Multiplied Immunoassay Technique | 1 | 1995 | 7 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2004 | 1751 | 0.010 |
Why?
|
Phenytoin | 1 | 1995 | 189 | 0.010 |
Why?
|
Treatment Failure | 1 | 2001 | 2664 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2001 | 3438 | 0.010 |
Why?
|
Phenobarbital | 1 | 1995 | 192 | 0.010 |
Why?
|
Carbamazepine | 1 | 1995 | 224 | 0.010 |
Why?
|
Ethambutol | 1 | 1974 | 59 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2001 | 1724 | 0.010 |
Why?
|
Syndrome | 1 | 2000 | 3274 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2003 | 1673 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2003 | 2008 | 0.010 |
Why?
|
Valproic Acid | 1 | 1995 | 444 | 0.010 |
Why?
|
Algorithms | 2 | 2004 | 14201 | 0.010 |
Why?
|
Isoniazid | 1 | 1974 | 288 | 0.010 |
Why?
|
Rifampin | 1 | 1974 | 351 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2004 | 5151 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 4413 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2000 | 1892 | 0.010 |
Why?
|
Observer Variation | 1 | 1995 | 2623 | 0.010 |
Why?
|
Protein Binding | 1 | 2001 | 9344 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 2000 | 2974 | 0.000 |
Why?
|
Acute Disease | 1 | 1996 | 7245 | 0.000 |
Why?
|
Software | 1 | 1999 | 4479 | 0.000 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2000 | 4056 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1974 | 6320 | 0.000 |
Why?
|
Age Factors | 1 | 2001 | 18435 | 0.000 |
Why?
|
Mass Screening | 1 | 2000 | 5457 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2000 | 10400 | 0.000 |
Why?
|
Health Care Costs | 1 | 1995 | 3270 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 15661 | 0.000 |
Why?
|
Risk Factors | 2 | 2001 | 74976 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2000 | 9442 | 0.000 |
Why?
|
Animals | 1 | 1993 | 169335 | 0.000 |
Why?
|
Incidence | 1 | 1996 | 21547 | 0.000 |
Why?
|
Cohort Studies | 1 | 1998 | 41808 | 0.000 |
Why?
|
Adolescent | 1 | 1995 | 89244 | 0.000 |
Why?
|